SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1

Immune response in COVID-19: what is next?

An omicron vocab lesson, from 'immune evasion' to 'outcompete' to 'epistasis' : Goats and Soda : NPR

Milder disease with Omicron: is it the virus or the pre-existing immunity?

Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?

Viruses, Free Full-Text

SARS-CoV-2 Brazilian variant may potentially escape T cell-mediated host immune responses

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine

Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1)

New study forecasts how SARS-CoV-2 variants could evade vaccines — Harvard Gazette

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway